Showing 1 - 20 results of 162,148 for search '(( 50 ((nn decrease) OR (_ decrease)) ) OR ((( _ linear decrease ) OR ( 2 a decrease ))))*', query time: 1.76s Refine Results
  1. 1

    Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

    Published 2014
    “…Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

    Published 2009
    “…(G) <i>klf2a</i> expression decreases after 15-h lidocaine treatment (90%, <i>n</i> = 67). …”
  8. 8
  9. 9

    HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

    Published 2021
    “…<b><a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001230#pbio.3001230.s007" target="_blank">S2 Data</a></b> provides the source data used for all graphs and statistical analyses. …”
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Factors associated with decreased FVC by multiple linear regression analysis. by Eun Kyung Jang (732099)

    Published 2015
    “…<p>R<sup>2</sup> =. 39</p><p>Factors associated with decreased FVC by multiple linear regression analysis.…”
  19. 19

    Bioluminescence decreased following <i>ex vivo</i> collagenase digestion of transgenic femora. by Sarah E. Mailhiot (766685)

    Published 2015
    “…(A) The femur showed a linear decrease (r = -0.619, p = 0.0452) after 6 hours in digestion. …”
  20. 20

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”